Hare Population Thriving in North Rhine-Westphalia, Germany – 2025 Update

Recent data from North Rhine-Westphalia (NRW), Germany, indicates a significant rebound in European hare (Lepus europaeus) populations, reaching 34 animals per square kilometer. However, this positive trend is threatened by the emergence of myxomatosis, a viral disease impacting hare populations across the region, prompting increased surveillance and research into effective mitigation strategies.

The resurgence of the European hare in NRW is a notable conservation success story, particularly given historical declines linked to habitat loss and intensive agriculture. This increase isn’t isolated to Germany; similar, albeit less dramatic, recoveries are being observed in neighboring countries. However, the shadow of myxomatosis looms large, potentially reversing these gains. Understanding the interplay between favorable environmental conditions, population dynamics, and emerging infectious diseases is crucial for ensuring the long-term viability of this species.

In Plain English: The Clinical Takeaway

  • Hare Populations are Up: The number of hares in a large region of Germany is increasing, which is good news for the local ecosystem.
  • Myxomatosis is a Threat: A viral disease, similar to one that affects rabbits, is spreading among hares and could cause significant illness and death.
  • Monitoring is Key: Scientists are closely watching the situation to understand how the disease spreads and how to protect the hare population.

The Epidemiology of Myxomatosis in European Hares

Myxomatosis is caused by the myxoma virus, a poxvirus initially identified in South American wild rabbits. Even as historically associated with rabbits (Oryctolagus cuniculus), the virus has demonstrated the capacity to infect and cause disease in European hares. The mechanism of action involves viral replication within dermal and subcutaneous tissues, leading to characteristic skin lesions, edema, and systemic illness. Transmission occurs primarily through biting insects, such as fleas, mosquitoes, and mites, acting as mechanical vectors. Direct contact with infected animals or contaminated fomites (inanimate objects) can also contribute to spread. The disease presents with a variable incubation period, typically ranging from 5 to 15 days, followed by clinical signs including conjunctivitis, fever, and the development of nodular skin lesions around the eyes, nose, and genitals. Mortality rates can be high, particularly in naive populations, with some outbreaks reporting losses exceeding 90% [1].

Geographical Impact and Regional Healthcare Response

The initial detection of myxomatosis in NRW in January 2023, followed by larger outbreaks in 2024, prompted a coordinated response from the Landesjagdverband (State Hunting Association) and veterinary authorities. This response mirrors broader European efforts to monitor and control the spread of the virus. The European Food Safety Authority (EFSA) has issued guidance on surveillance and reporting of myxomatosis outbreaks in wild rabbit and hare populations. The current situation in NRW is particularly concerning given the region’s high hare density, creating ideal conditions for rapid viral transmission. The Kölner Bucht (Cologne Bucht) and Soester Börde regions, characterized by extensive agricultural landscapes, are identified as hotspots. These areas provide ample habitat and foraging opportunities for hares, but also facilitate vector-borne disease transmission. The impact extends beyond ecological concerns; hare populations play a role in agricultural ecosystems, influencing vegetation dynamics and serving as a prey base for predators. A significant decline in hare numbers could have cascading effects on the broader food web.

Understanding Hare Population Dynamics and Counting Methodology

The methodology employed by the Landesjagdverband for hare population assessment involves twice-yearly surveys conducted during spring and autumn. These surveys utilize standardized transect counts, where observers drive along predetermined routes at night, employing handheld spotlights to detect hares. The consistency of route selection is critical for ensuring data comparability over time. A second count is performed to validate the initial results; if the two counts differ by more than 25%, a third count is undertaken to improve accuracy. This approach, while relatively simple, provides a valuable index of hare abundance. However, it’s important to acknowledge the limitations of this method. Detection probability can be influenced by factors such as weather conditions, observer experience, and hare behavior. More sophisticated techniques, such as camera trapping and mark-recapture studies, could provide more precise estimates of population size and demographic parameters.

The Role of Climate and Habitat in Hare Recovery

The observed increase in hare populations in 2025 is largely attributed to favorable weather conditions – a mild, dry winter followed by a spring with limited rainfall. These conditions are particularly beneficial for hares, which originated in steppe environments and are well-adapted to open landscapes. NRW’s characterization as a lowland agricultural region with extensive open areas and a temperate Atlantic climate further contributes to its suitability for hare habitation. However, the intensification of agriculture, including the use of pesticides and the loss of hedgerows, continues to pose a threat to hare habitat. Balancing agricultural productivity with biodiversity conservation is a key challenge for land managers in the region.

Myxomatosis Vaccine Development and Future Research

Currently, there is no commercially available vaccine specifically licensed for use in European hares. However, research is underway to develop effective immunization strategies. One approach involves adapting rabbit myxomatosis vaccines for use in hares, although efficacy and safety necessitate to be carefully evaluated. Another avenue of investigation focuses on developing novel vaccine candidates based on recombinant viral vectors or subunit vaccines. The challenge lies in generating a robust immune response in hares without causing adverse reactions. Understanding the genetic diversity of myxoma virus strains circulating in hare populations is crucial for designing vaccines that provide broad protection.

Myxomatosis Outbreak Data (NRW, 2023-2025)
Year Number of Confirmed Cases Affected Regions Estimated Mortality Rate
2023 15 Isolated pockets in the Münsterland 20%
2024 120 Kölner Bucht, Soester Börde, and surrounding areas 45%
2025 (to date) 85 Continued outbreaks in previously affected regions, with some spread to new areas 35%

Contraindications & When to Consult a Doctor

While myxomatosis primarily affects lagomorphs (rabbits and hares), it’s crucial for the general public to understand the limited risk of zoonotic transmission (spread from animals to humans). Human infection with myxoma virus is extremely rare and typically occurs only in laboratory settings or through accidental exposure to infected animal tissues. However, individuals who handle potentially infected animals should practice strict hygiene measures, including wearing gloves and washing hands thoroughly with soap and water. If you observe unusual skin lesions or flu-like symptoms after contact with a hare or rabbit, consult a physician immediately. Pet owners should ensure their rabbits are vaccinated against myxomatosis and practice preventative measures to minimize exposure to biting insects.

The situation in NRW underscores the importance of proactive wildlife disease surveillance and the need for integrated conservation strategies that address both habitat loss and emerging infectious diseases. Continued monitoring of hare populations, coupled with research into effective disease control measures, will be essential for safeguarding the future of this iconic species.

References

Photo of author

Dr. Priya Deshmukh - Senior Editor, Health

Dr. Priya Deshmukh Senior Editor, Health Dr. Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

Gazeta Express: Copyright & Legal Information

Messenger Stories & Family Communication

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.